The influence of sensitivity to fungal allergens on the development and course of allergic diseases of the respiratory tract;Wpływ wystȩpowania nadwrażliwości na alergeny grzybów na rozwój i przebieg chorób alergicznych układu oddechowego

Pneumonologia i Alergologia Polska

Volumn 76, Issue 1, 2008, Pages 29-36

  Semik Orzech, Aleksandra ^a   Barczyk, Adam ^a   Pierzchała, Władysław ^a  

^a Katedra i Klinika Pulmonologii la skiego   (Poland)

Author keywords

Allergic diseases; Bronchial asthma; Molds; Prevalence

Indexed keywords

FUNGUS ANTIBODY; FUNGUS ANTIGEN; IMMUNOGLOBULIN E;

BLOOD; FUNGUS; HUMAN; IMMUNOLOGY; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT DISEASE; REVIEW; SKIN TEST;

ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; FUNGI; HUMANS; IMMUNOGLOBULIN E; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY TRACT DISEASES; SKIN TESTS;

EID: 40749132027     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Brown W.D. Mould allergy affecting the ears, nose and throat. Otolaryng. Clin. N. Amer. 1971; 4: 3.
2. Lacey J. Fungi and Actinomycetes as allergen. W: Kay A.B. Allergy and allergic diseases. Blackwell Science, London 1997.
3. Woodcock A.A., Forster L., Matthews E. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N. Engl. J. Med. 2003; 349: 225-236.
4. Katz Y., Verleger H., Barr J. i wsp. Indoor survey of moulds and prevalence of mould atopy in Israel. Clin. Exp. Allergy 1999; 29: 148-149.
5. Modrzyński M., Zawisza E. Specific nasal provocation tests in patients hypersensitive to mould allergens. Med. Sci. Monit. 2005; 11: 44-48.
6. Lipiec A. Nadwrażliwość na grzyby pleśniowe u chorych na alergiczne zapalenie błony śluzowej nosa. Rozprawa na stopień doktora nauk medycznych. Warszawa 1999.
7. D'Amato G., Spieksma F.T. Aerobiologic and clinical aspects of mould allergy in Europe. Allergy 1995; 50: 870-877.
8. Kauffman H.F. Fungal allergy and immune demence. W: Aerobiological and clinical aspects of allergic moulds. EAACI Aerobiology Subcommitee Course Sylabus, Rhodes 1977.
9. Garrett M.H., Rayment P.R., Hooper M.A., Abramson M.J., Hooper B.M. Indor airborne fungal spores, house dampness and associations with environmental factor and respiratory health in children. Clin. Exp. Allergy 1998; 28: 459-467.
10. Pirhonen I., Nevalainen A., Husman T., Pekkanen J. Home dampness, moulds and their influence on respiratory infections and symptoms in adults in Finland. Eur. Respir. J. 1996; 9: 2618-2622.
11. Gravesen S., Frisvad J.C., Samson R.A. i wsp. Microfungi. Munksgaard, Copenhagen 1994.
12. Lipiec A., Rapiejko P., Samoliński B. Uczulenie na alergeny grzybów z rodzaju Alternaria i Cladosporium u chorych z alergicznym nieżytem nosa, Ann. Univerist. Marie Curie-Skłodowskiej Sectio EEE. Horticultura 2003; 13: 389-395.
13. Rapiejko P., Lipiec A., Emeryk A. Annual total amount of pollen and the frequency of positive skin trick test results to pollen allergen. Pol. J. Environ. Studies 2006; 15: 653-660.
14. D'Amato G., Chatzigeorgiou G., Corsico R. i wsp. Evaluation of the prevalence of skin trick test positivity to Alternaria and Cladosporium in patients with suspected respiratory allergy. A European multicenter study promoted by the Subcommitee on Aerobiology and Environmental Aspects of Inhalant Allergen of the European Academy of Allergology and Clinical Immunology. Allergy 1997; 52: 711-716.
15. Ezeamuzie C.I., Al-Ali S., Khan M. i wsp. IgE-mediated sensitization to mould allergen among patients with allergic respiratory diseases in a desert environment. Int. Arch. Allergy Immunol. 2000; 121: 300-307.
16. Mari A., Schneider P., Wally V., Breitenbach M., Simon-Nobbe B. Sensitization to fungi: epidemiology, comparative skin tests and IgE reactivity of fungal extracts. Clin. Exp. Allergy 2003; 33: 1429-1438.
17. Nolles G., Hoekstra M.O., Schouten J.P., Gerritsen J., Kauffman H.F. Prevalence of immunoglobulin E for fungi in atopic children. Clin. Exp. Allergy 2001; 31: 1564-1570.
18. Reijula K., Leino M., Mussalo-Rauhamaa H. i wsp. IgE-mediated allergy to fungal allergen in Finland with special reference to Alternaria alternate and Cladosporium Herbarum. Ann. Allergy Astma Immunol. 2003; 91: 280-287.
19. Govi V. Aerial diffusion of phytopathogenic fungi. Aerobiologia 1992; 8: 84-93.
20. Rapiejko P., Lipiec A., Modrzyński M. Treshold pollen concentration necessary to evoke allergic symptoms. Int. Rev. Allergol. Clin. Immunol. 2004; 10: 91-94.
21. Denning D.W., O'Driscoll B.R., Hogaboam C.M., Bowyer P., Niven R.M. The link between fungi and severe asthma: a sumary of the evidence. Eur. Respir. J. 2006; 27: 615-626.
22. Kheradmand F., Kiss A., Xu J., Lee S.H., Kolattukudy P.E., Corry D.B. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J. Immunol. 2002; 169: 5904-5911.
23. Nigam S., Ghosh P.C., Sarma P.U. A new glycoprotein allergen//antigen with the protease activity from Aspergillus fumigatus. Int. Arch. Allergy Immunol. 2003; 132: 124-131.
24. Papuas G.P., Herbert R.J., Henderson W. The respiratory effects of volatile organic compounds. Int. J. Occup. Environ. Heath 2000; 6: 1-8.
25. Fogelmark B., Thorn J., Rylander R. Inhalation of beta-D-glucan causes airway eosinophilia. Mediators Inflamm. 2001; 10: 13-19.
26. Beijer L., Thorn J., Rylander R. Mould exposure at home related to inflammatory markers in blood. Eur. Respir. J. 2003; 2: 317-322.
27. Crameri R., Faith A., Hemmann S. i wsp. Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus. J. Exp. Med. 1996; 184: 265-270.
28. Flückiger S., Scapozza L., Mayer C., Blaser K., Folkers G., Crameri R. Immunological and structural analysis of IgE-mediated cross-reactivity between manganese superoxide dismutases. Int. Arch. Allergy Immunol. 2002; 128: 292-303.
29. Beaumont F., Kauffman H.F., de Monchy J.G., Sluiter H.J., de Vries K. Volumetric aerobiological survey of conidial fungi in the north-east Neatherlands. Comparison of aerobiological data and skin tests with mould extracts in an asthmatic population. Allergy 1985; 40: 181-186.
30. O'Driscoll R.B., Hopkinsom L., Denning D.W. Mold sensitisation allergy is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm. Med. 2005; 5: 4.
31. Zureik M., Neukirch C., Leynaert B. i wsp. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community Respiratory Heath Survey. BMJ 2002; 325: 411-415.
32. Black P.N., Udy A.A., Brodie S.M. Sensitivity to fungal allergen is a risk factor for life-uhreatening asthma. Allergy 2000; 55: 501-504.
33. Burrows B., Martinez F.D., Halonen M., Barbee R.A., Cline M.G. Association of asthma with serum IgE levels and skin test reactivity to common allergen. N. Engl. J. Med. 1989; 320: 271-277.
34. O'Hollaren M.T., Yunginger J.W., Offord K.P. i wsp. Exposure to aeroallergen as a possibile precipitating factor in respiratory agrest in young patients with asthma. N. Engl. J. Med. 1991; 324: 359-363.
35. Targonski P.V., Persky V.W., Ramekrishan V. Effect of environmental molds on risk of heath from asthma during the pollen season. J. Allergy Clin. Immunol. 1995; 95: 955-961.
36. Langley S.J., Goldthorpe G., Truman N. Impaired lung function in astma is associated with sensitisation to airborne moulds. Am. J. Respir. Crit. Care Med. 2004; 169: A309.
37. Delfino R.J., Zeiger R.S., Seltzer J.M. i wsp. The effect of outdoor fungal spore concentrations on daily astma severity. Environ. Heath Perspect. 1997; 105: 622-635.
38. Jenkins P.F., Mullins J.K., Davies B.H., Williams D.A. The possible role of aero-allergens in the epidemic asthma deaths. Clin. Allergy 1981; 11: 611-620.
39. Boulet L.P., Turcotte H., Laprise C. i wsp. Comparative degree and type of sensitisation to common indor and outdoor allergen in subjects with allergic rhinitis and/or asthma. Clin. Exp. Allergy 1997; 27: 52-59.
40. Neukirch C., Henry C., Leynaert B., Liard R., Bousquet J., Neukirch F. Is sensitisation to Alternaria alternata a risk factor for severe asthma? A population-based study. J. Allergy Clin. Immunol. 1999; 103: 709-711.
41. Khot A., Burn R. Seasonal variation and time trends of deaths from asthma in England and Wales 1960-1982. BMJ 1984; 289: 233-234.
42. Latgé J.P. Aspergillus fumigatus and Aspergillosis. Clinical Microbiology Reviews 1999; 12: 310-350.
43. Gibson P.G. Allergic bronchopulmonary aspergillosis. Semin. Respir. Crit. Care Med. 2006; 27: 185-191.
44. Stevens D.A., Schwartz H.J., Lee J.Y. i wsp. A randomized trial of itraconasole in allergic bronchopulmonary aspergillosis. N. Engl. J. Med. 2000; 11: 756-762.
45. Wark P.A., Hensley M.J., Saltos N. i wsp. Anti-inflammatory effect of itraconasole in stable allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol. 2003; 111: 952-957.
46. Riding D., Denning D., Francis H.C. The effect of itraconasole therapy in severe asthma patients allergic to Aspergillus: a retrospective audit. Abstr. 75: Advances against aspergillosis. www.Aspergillus.man.ac.uk
47. Ward G.W., Woodfolk J.A., Hayden M.L., Jackson S., Platts-Mills T.A. Treatment of late-onset asthma with fluconasole. J. Allergy Clin. Immunol. 1999; 104: 541-546.
48. Ponikau J.U., Sherris D.A., Kita H., Kern E.B. Intranasal antifungal treatment in 51 patients with chronic rhino-sinusitis. J. Allergy Clin. Immunol. 2002; 110: 862-866.